Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.

Antimicrobial agents and chemotherapy - 1 Feb 2000

Boyle-Vavra S, Berke S K, Lee J C, Daum R S

Abstract excerpt

The recent identification of glycopeptide intermediate-resistant Staphylococcus aureus (GISA) clinical isolates has provided an opportunity to assess the stability of the glycopeptide resistance phenotype by nonselective serial passage and to evaluate reversion-associated cell surface changes. Three GISA isolates from the United States (MIC of vancomycin = 8 microg/ml) and two from Japan (MICs of vancomycin = 8...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrophoresis, Gel, Pulsed-Field

Share to Glycopeptides

Share to Microbial Sensitivity Tests

Share to Serotyping

Share to Staphylococcus aureus

Share to Vancomycin Resistance

Source

Open in PubMed Open full text

Identifiers

PMID: 10639349
DOI: 10.1128/AAC.44.2.272-277.2000
PMCID: PMC89670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.PMID 10639349Read ↗

Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.Semantic proximity Read ↗

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.Semantic proximity Read ↗

Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in <i>Staphylococcus aureus</i>Semantic proximity Read ↗

Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.Semantic proximity Read ↗

Resistance to Autolysis in Vancomycin-Selected Staphylococcus aureus Isolates Precedes Vancomycin-Intermediate ResistanceSemantic proximity Read ↗

Unstable Vancomycin Heteroresistance Is Common among Clinical Isolates of Methiciliin-Resistant <i>Staphylococcus aureus</i>Semantic proximity Read ↗

Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus During Treatment of BacteremiaSemantic proximity Read ↗

In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.Semantic proximity Read ↗

Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to VancomycinSemantic proximity Read ↗

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.Semantic proximity Read ↗

A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical <i>Staphylococcus aureus</i> IsolatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.